High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients.

High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients.
复制标题

入院时天冬氨酸转氨酶与丙氨酸转氨酶比率高是 COVID-19 患者预后不良的危险因素

DOI:
10.1038/s41598-020-73575-2
复制
发表时间:
2020-10-05
期刊:
影响因子:
4.6
通讯作者:
Wang Y
Wang Y
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Qin C;Wei Y;Lyu X;Zhao B;Feng Y;Li T;Cao H;Yang X;Zhou X;Wang W;You L;Wang Y

文献摘要

参考文献

被引文献

相似文献

本研究旨在分析COVID-19患者的天冬氨酸氨基转移酶(AST)与丙氨酸氨基转移酶(ALT)比值。排除后,567例住院患者纳入本研究,并根据其入院时的AST/ALT比值分为两组。本研究中死亡被视为预后不良。567例患者中,200例(35.3%)AST/ALT ≥ 1.38。在200例患者中,年龄较大(中位年龄60岁)、肌痛(64例[32%]病例)、疲劳(91例[45.5%]病例)、一些合并症和结局与AST/ALT < 1.38的患者有显著差异。他们的胸部计算机断层扫描(CT)结果、实验室检查结果和严重程度评分也更差。血小板计数(OR 0.995,95% CI [0.992-0.998])和血红蛋白(OR 0.984,95% CI [0.972-0.995])水平与入院时AST/ALT ≥ 1.38独立相关。此外,入院时AST/ALT比值高是预后不良的独立危险因素(OR 99.9,95% CI [2.1-4280.5])。在随后的监测中,幸存者和非幸存者在住院期间均显示AST/ALT比值下降。总之,高AST/ALT比值可能是COVID-19患者病情和结局恶化的指征。
This study aimed to analyze aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio in COVID-19 patients. After exclusion, 567 inpatients were included in this study and separated into two groups according to their AST/ALT ratio on admission. Death was regarded as poor prognosis in this study. Of 567 patients, 200 (35.3%) had AST/ALT ≥ 1.38. Of the 200 patients, older age (median age 60 years), myalgia (64 [32%] cases), fatigue (91 [45.5%] cases), some comorbidities and outcomes were significantly different from patients with AST/ALT < 1.38. They also had worse chest computed tomography (CT) findings, laboratory results and severity scores. Levels of platelet count (OR 0.995, 95% CI [0.992–0.998]) and hemoglobin (OR 0.984, 95% CI [0.972–0.995]) were independently associated with AST/ALT ≥ 1.38 on admission. Furthermore, a high AST/ALT ratio on admission was an independent risk factor for poor prognosis (OR 99.9, 95% CI [2.1–4280.5]). In subsequent monitoring, both survivors and non-survivors showed decreased AST/ALT ratio during hospitalization. In conclusion, high AST/ALT ratio might be the indication of worse status and outcomes in COVID-19 patients.
DOI: 10.1155/2020/8743548
发表时间: 2020-03-23
影响因子: 2.1
作者:
Wang, Jinxin;Li, Jiawen;Qiu, Huixian
通讯作者: Qiu, Huixian
DOI: 10.1177/1758835919900872
发表时间: 2020-04-01
影响因子: 4.9
作者:
Riedl, Jakob Michael;Posch, Florian;Gerger, Armin
通讯作者: Gerger, Armin
DOI: 10.1016/j.cimid.2007.05.009
发表时间: 2007-09
期刊: Comparative immunology, microbiology and infectious diseases
影响因子: --
作者:
Feng Y;Gao GF
通讯作者: Gao GF
中国武汉市 138 例 2019 新型冠状病毒感染肺炎住院患者的临床特征。
DOI: 10.1001/jama.2020.1585
发表时间: 2020-03-17
影响因子: 120.7
作者:
Wang, Dawei;Hu, Bo;Peng, Zhiyong
通讯作者: Peng, Zhiyong
DOI: 10.1056/nejmoa2002032
发表时间: 2020-04-30
影响因子: 158.5
作者:
Guan, W.;Ni, Z.;Zhong, N.
通讯作者: Zhong, N.